Claudia Ana Burillo Vargas

Institutions of which they are part

Liver Diseases

Vall Hebron Institut de Recerca

Claudia Ana Burillo Vargas

Institutions of which they are part

Liver Diseases

Vall Hebron Institut de Recerca

Related news

Vall d’Hebron participates in a consensus to optimize equity in access to liver transplant

The consensus establishes recommendations that could correct the current disparities related to muscle mass, weight and height and would allow for more precise prioritization of patients who require transplants more urgently.

We develop a method to diagnose fatty liver in a quantitative and non-invasive way

Using computed tomography (CT), with or without contrast, it is possible to perform an accurate and safe detection of the disease without the need for biopsies and avoiding the limitations of other non-invasive diagnostic tools.

Pacient d'un assaig clínic a la consulta

VHIR exceeds 700 active clinical trials to achieve new therapies for patients

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.